Ciprofloxacin Tablets USP, 500 mg, 100-count bottle, Rx only, Manufactured for West-ward Pharmaceutical Corp., Eatowntown, NJ 07724 by Hikma Pharmaceuticals, Amman, Jordan, NDC 0143-9928-01
Published April 3, 2013 · Recall initiated: February 6, 2013
Summary
FDA records drug Class II recall D-220-2013, published April 3, 2013 and initiated February 6, 2013. Recalling firm: West-ward Pharmaceutical Corp.; Status: Terminated; Reported quantity: 7,136 units; Lot: Lot #: CB222A, Exp 06/16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Substance(s): A complaint was received for a rubber-like material in a 500 mg Ciprofloxacin tablet.
What to do
Voluntary: Firm initiated · Letter
Get an email if CIPROFLOXACIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CIPROFLOXACIN
- Manufacturer
- West-ward Pharmaceutical Corp.
- Distributor
- GA, AR
- Lot
- Lot #: CB222A, Exp 06/16
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACiprofloxacin Tablets, USP, 750 mg, 50-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O. BoxNovember 11, 2026
- FDACiprofloxacin Tablets, USP, 500 mg, 100-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O.November 11, 2026
- FDACiprofloxacin Ophthalmic Solution USP, 0.3% as base, package in 5 mL bottles, Rx Only, Distributed by: LeadingMarch 26, 2025
- FDACiprofloxacin Ophthalmic Solution USP, 0.3% as base, Sterile, package in 5 mL bottles, Rx Only, DistributedJanuary 15, 2025
- FDATORISEL Kit (temsirolimus) injection, 25 mg/mL, CONCENTRATED, Rx Only, Packaged in a carton containing 1 vialApril 3, 2013
- FDAPHYSICIANS TOTAL CARE, TETRACYCLINE, 250 mg, 30 CAPSULES, bottle MFG. BY: TEVA PHARMACEUTICALS USA,April 3, 2013
Questions about this recall
Was Ciprofloxacin Tablets USP, 500 mg, 100-count bottle, Rx only, Manufactured for West-ward Pharmaceutical Corp., Eatowntown, NJ 07724 by Hikma Pharmaceuticals, Amman, Jordan, NDC 0143-9928-01 recalled?
Yes. FDA published recall D-220-2013 on April 3, 2013. Reported hazard: Presence of Foreign Substance(s): A complaint was received for a rubber-like material in a 500 mg Ciprofloxacin tablet.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CIPROFLOXACIN.